We employ modern and scientific treatment methods aimed at the recovery of our patients and the improvement of their quality of life.

Multiple Sclerosis is a chronic disease that typically begins between the ages of 20 and 40, affecting young adults; it primarily targets the white matter of the brain and spinal cord, involves the immune system, and results in clinical complications.

The hallmark of the disease is forgetfulness. Any form of forgetfulness in old age warrants evaluation. The crucial task is to distinguish between normal, age-related forgetfulness and forgetfulness that serves as a symptom of the disease. This distinction is made through a clinical examination of the patient, information provided by the patient's family, and neuropsychological assessments that evaluate brain function...

Although a patient is considered to have epilepsy if they experience two or more unprovoked seizures at least 24 hours apart, a diagnosis of epilepsy generally requires a comprehensive neurological examination, blood tests, and various other assessments to detect any abnormalities.

If a patient experiences pain once or twice a month, treatment is recommended only during an attack. In such cases, it is necessary to administer treatment before the pain intensifies. If the pain occurs more frequently, a prophylactic treatment plan—designed to reduce the frequency and severity of attacks and prevent pain—should be implemented.